DEA Adds Metonitazene to Schedule I Drug List
The Drug Enforcement Administration permanently placed the synthetic benzimidazol-opioid metonitazene on Schedule I of the Controlled Substances Act, it said in a final order released Aug. 17. The substance had already been temporarily listed in Schedule I since 2022 (see…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
2204110029). The final order is set to take effect Sept. 18.